BPH Global Ltd (AU:BP8) — Market Cap & Net Worth
Market Cap & Net Worth: BPH Global Ltd (BP8)
BPH Global Ltd (AU:BP8) has a market capitalization of $3.33 Million (AU$4.71 Million) as of August 6, 2026. Listed on the AU stock exchange, this Australia-based company holds position #29263 globally and #1637 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BPH Global Ltd's stock price AU$0.00 by its total outstanding shares 2353484651 (2.35 Billion). See capital reinvestment ratio of BPH Global Ltd to understand how much of operating cash flow is reinvested back into capital assets.
BPH Global Ltd Market Cap History: 2015 to 2026
BPH Global Ltd's market capitalization history from 2015 to 2026. Data shows change from $732.71 Million to $3.33 Million (-42.59% CAGR).
BPH Global Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BPH Global Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
9.45x
BPH Global Ltd's market cap is 9.45 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $116.57 Million | $74.75K | -$35.62 Million | 1559.36x | N/A |
| 2017 | $333.05 Million | $31.62K | -$3.63 Million | 10533.16x | N/A |
| 2018 | $158.20 Million | $290.68K | -$3.35 Million | 544.23x | N/A |
| 2019 | $116.57 Million | $1.56 Million | -$3.54 Million | 74.65x | N/A |
| 2020 | $158.20 Million | $730.36K | -$1.58 Million | 216.60x | N/A |
| 2021 | $116.57 Million | $8.50 Million | -$3.13 Million | 13.72x | N/A |
| 2023 | $12.49 Million | $339.00 | -$4.32 Million | 36841.60x | N/A |
| 2024 | $5.00 Million | $109.97K | -$2.27 Million | 45.43x | N/A |
| 2025 | $3.33 Million | $352.38K | -$1.49 Million | 9.45x | N/A |
Competitor Companies of BP8 by Market Capitalization
Companies near BPH Global Ltd in the global market cap rankings as of August 6, 2026.
Key companies related to BPH Global Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #507 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #540 globally with a market cap of $49.86 Billion USD ( CN¥340.77 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #554 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #626 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #507 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #540 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $49.86 Billion | CN¥53.42 |
| #554 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.20 |
| #626 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.70 |
BPH Global Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, BPH Global Ltd's market cap moved from $732.71 Million to $ 3.33 Million, with a yearly change of -42.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$3.33 Million | 0.00% |
| 2025 | AU$3.33 Million | -33.33% |
| 2024 | AU$5.00 Million | -60.00% |
| 2023 | AU$12.49 Million | -89.29% |
| 2021 | AU$116.57 Million | -26.32% |
| 2020 | AU$158.20 Million | +35.71% |
| 2019 | AU$116.57 Million | -26.32% |
| 2018 | AU$158.20 Million | -52.50% |
| 2017 | AU$333.05 Million | +185.71% |
| 2016 | AU$116.57 Million | -84.09% |
| 2015 | AU$732.71 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 5th, 2026 the market cap of BPH Global Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.33 Million USD |
| MoneyControl | $3.33 Million USD |
| MarketWatch | $3.33 Million USD |
| marketcap.company | $3.33 Million USD |
| Reuters | $3.33 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BPH Global Ltd
BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics… Read more